Alberto Epstein

Alberto Epstein serves as the Chief Scientific Officer at EG427, specializing in molecular virology and gene therapy since July 2019. Prior to this role, Alberto Epstein held the position of Directeur de recherche at UVSQ Université de Versailles Saint-Quentin-en-Yvelines from January 2013 to December 2018, where Alberto Epstein was involved in the HandiMedEx research program. From January 1980 to December 2012, Alberto Epstein worked at CNRS, initially as a Chargé de recherche and advancing to Directeur de recherche in 1987. Alberto Epstein directed the molecular genetics laboratory of the HSV-1 virus at the Centre de Génétique Moléculaire et Cellulaire starting in 1990.